Equine Cushing’s disease is one of the most common disease syndromes to affect horse health, according to the National Equine Health Survey in 2018*. It is estimated that 20% of horses and ponies over ...
Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses Zygolide® is ...